CD152 Recombinant Protein

Reference: PX-P4108-100
Product nameCD152 Recombinant Protein
Uniprot IDP16410
Uniprot linkhttp://www.uniprot.org/uniprot/P16410
Origin speciesHomo sapiens (Human)
Expression systemEukaryotic expression
SequenceMACLGFQRHKAQLNLATRTWPCTLLFFLLFIPVFCKAMHVAQPAVVLASSRGIASFVCEYASPGKATEVRVTVLRQADSQVTEVCAATYMMGNELTFLDDSICTGTSSGNQVNLTIQGLRAMDTGLYICKVELMYPPPYYLGIGNGTQIYVIDPEPCPDSD
Molecular weight18.51kDa
Protein delivered with Tag?C-terminal His Tag
Purity estimated>90% by SDS-PAGE
BufferPBS pH7.5
Delivery conditionDry Ice
Storage conditionStore at - 20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage.
BrandProteoGenix
Host speciesMammalian cells
ApplicationsELISA,WB
Fragment TypeMet1~Asp161
Aliases /SynonymsCD152
ReferencePX-P4108
NoteFor research use only

Description of CD152 Recombinant Protein

General information on CD152 Recombinant Protein:

CD152, also known as CTLA4 and cytotoxic T lymphocyte protein 4, is a single-pass type I membrane protein and a member of the immunoglobulin superfamily. It is the second member of the CD28 receptor. The ligands or counterreceptors of these two proteins belong to the B7, CD8 (B7-1) and CD86 (B7-2) families. CTLA4 delivers inhibitory signals to T lymphocytes, while CD28 delivers stimulatory signals. Intracellular CTLA4 is also present in regulatory T cells and may play an important role in its function. CD152 antigen or cytotoxic T lymphocytes (CTLA-4) are important receptors involved in downregulating T-cell activation. Due to its far-reaching inhibitory effect, CD152 is considered a candidate solid acceptable for autoimmunity and a convincing target for cancer immunotherapy. In particular, recent evidence suggests that CD152 is also important in homeostasis and the function of population suppressor cells called regulatory T cells (Treg).

Tremelimumab Biosimilar - Anti-CTLA4, CD152 mAb binds to CD152 Recombinant Protein in indirect ELISA Assay

Immobilized CD152 Recombinant Protein (cat. No.PX-P4108) at 0.5µg/mL (100µL/well) can bind to Tremelimumab Biosimilar - Anti-CTLA4, CD152 mAb (cat. No.PX-TA1177) in indirect ELISA with Goat Anti-Human IgG secondary antibody coupled with HRP measured by OD450

Reviews

Il n’y a pas encore d’avis.

REVIEW YOUR PRODUCT

Soyez le premier à laisser votre avis sur “CD152 Recombinant Protein”

Votre adresse e-mail ne sera pas publiée. Les champs obligatoires sont indiqués avec *

Related products

Tremelimumab Biosimilar – Anti-CTLA4, CD152 mAb – Research Grade
Biosimilar

Tremelimumab Biosimilar – Anti-CTLA4, CD152 mAb – Research Grade

PX-TA1177 400€
Zalifrelimab  Biosimilar – Anti-CTLA4, CD152 mAb – Research Grade
Biosimilar

Zalifrelimab Biosimilar – Anti-CTLA4, CD152 mAb – Research Grade

PX-TA1559 400€
Nurulimab  Biosimilar – Anti-CTLA4 mAb – Research Grade
Biosimilar

Nurulimab Biosimilar – Anti-CTLA4 mAb – Research Grade

PX-TA1597 400€
Botensilimab Biosimilar – Anti-CTLA4 mAb – Research Grade
Biosimilar

Botensilimab Biosimilar – Anti-CTLA4 mAb – Research Grade

PX-TA1647 400€
Cadonilimab Biosimilar – Anti-PDCD1;CTLA4 mAb – Research Grade
Biosimilar

Cadonilimab Biosimilar – Anti-PDCD1;CTLA4 mAb – Research Grade

PX-TA1648 400€
Erfonrilimab Biosimilar – Anti-CD274;CTLA4 mAb – Research Grade
Biosimilar

Erfonrilimab Biosimilar – Anti-CD274;CTLA4 mAb – Research Grade

PX-TA1665 400€
Lorigerlimab Biosimilar – Anti-CTLA4 & PD1 mAb – Research Grade
Biosimilar

Lorigerlimab Biosimilar – Anti-CTLA4 & PD1 mAb – Research Grade

PX-TA1765 400€
Tuvonralimab Biosimilar – Anti-CTLA4 mAb – Research Grade
Biosimilar

Tuvonralimab Biosimilar – Anti-CTLA4 mAb – Research Grade

PX-TA1781 400€
Bavunalimab Biosimilar – Anti-LAG3;CTLA4 mAb – Research Grade
Biosimilar

Bavunalimab Biosimilar – Anti-LAG3;CTLA4 mAb – Research Grade

PX-TA1813 400€
Human CD138/SDC1 Monoclonal Antibody
Monoclonal Antibody

Human CD138/SDC1 Monoclonal Antibody

FHD30810 330€

Cart (0 Items)

Your cart is currently empty.

View Products